Reading time: 6 minutes Anthony Tao Bacteria are not often given the respect they sometimes deserve. People tend to consider them as foreign harbingers of plagues, colds, and rashes ‒ unwanted invaders that our immune systems are uniquely tasked to deport. Of course, it is very well accepted now that many of these microbes indeed... Continue Reading →
Reading time: 4 minutes Aishwarya Subramanian At Oncobites we've covered the exciting emerging field of immunotherapy to treat cancer, some of which include PROTACs and BiTE molecules . Recently, significant advances have been made when trying to come up with cutting edge ideas for cancer treatment. With the recent changes in the landscape of cancer... Continue Reading →
Reading time: 4 minutes Manisit Das From the early days of OncoBites, we are trying to share with you the reasons we get cancer. Cancer arises when the DNA in our cells is altered due to irreparable mistakes in the cellular machinery or environmental effects. If a mistake happens in the proteins that help repair... Continue Reading →
Reading time: 3 minutes Aishwarya Subramanian Cancer immunotherapy has gained a lot of traction in the last few years, as several novel therapeutics have made their way into the clinic. Among these new therapeutics, bispecific antibodies are some of the most unique. Unlike traditional antibodies, which have two arms that bind to the same molecule,... Continue Reading →
Reading time: 6 minutes Payal Yokota Despite the advent and access to a variety of targeted immunotherapy approaches, the current paradigm for solid tumors still remains if you can cut it out – you do! Depending on the grade of tumor and degree of metastasis, there’s a substantial risk of tumor resurgence. In those cases,... Continue Reading →
OncoBites 